Skip to main content
Caplight Logo









NousQ

NousQ

Private
SingaporeHealthcare & Life Scienceshttps://www.nousq.com/

Last Round

VC Round

Jun 9, 2025

Total Funding Raised

$9.02M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

NousQ operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a VC Round in June 2025.

NousQ is a medical device company that develops patient-centric robotic and sensor-controlled solutions for ear-related problems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Industrial Robotics

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

NousQ Comparables

Compare NousQ with similar companies based on industry and business-model similarity.

NousQ comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Karl Storz SE & Co. KG
84%
Preceptis Medical
81%
Collin SAS
78%
Book a demo to see all comparables

For institutional investors. Book with your work email.

NousQ Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 9, 2025
AcceleratorSep 26, 2022
SeedOct 1, 2021
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Chee Wee Gan

CTO

Executive Team

For institutional investors. Book with your work email.

NousQ Investors

Notable investors and investment history

NousQ investors
InvestorRounds
Startup SGAccelerator
MedTech InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors grew 34% MoM, reaching 2.4K.

  • Jul 24, 2026

    Monthly visitors increased 46% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

NousQ Filings

Explore SEC and related filing metadata, where available.

NousQ filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about NousQ's valuation, stock price, and market status.

Is NousQ a public or private company?

NousQ is a private company.

What is the current stock price of NousQ?

NousQ is a private company, so its shares have no public market price. Caplight tracks NousQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is NousQ worth (valuation)?

Valuation information for NousQ is not publicly available.

Can I buy NousQ stock?

NousQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was NousQ's last funding round?

NousQ's most recent funding round was VC Round on June 9, 2025.

Who are the main investors in NousQ?

Key investors in NousQ include Startup SG, MedTech Innovator.

Will NousQ IPO soon?

No public IPO plans have been announced for NousQ.

How can I track NousQ secondary market activity?

Caplight tracks bids, offers, and trades in NousQ's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range6
Year Founded2021
Last FundingJun 9, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?